Conversation

Replying to
For sure, although I, personally, would want one even after seeing e.g., animal challenge trial data. The thing I really wish is that we'd started these trials in April when we identified Delta, in which case we'd be done with all of that by now..
1
This Tweet is from a suspended account. Learn more
Replying to
Well, yes, but I expect that they would have done that under a different regulatory (and vaccine purchasing) regime, which is what I would advocate for. I don't think it's fair to pin this on the companies in this case.
1
This Tweet is from a suspended account. Learn more
This Tweet is from a suspended account. Learn more
This Tweet is from a suspended account. Learn more
Replying to
Uh, I think we are using words in different ways here. The regulatory framework is definitely an obstacle for the vaccine boosters (and in your day job example), at least as I mean it. At minimum, in the absence of the regulator at all, neither of those things would be held up.
2
Replying to and
We could also see how regulatory choices affect decision making by companies on the margin. For example, the R&D costs for enough trial data to convince me to take a booster dose are small: probably less than $100k. At the price I'd pay for one, it's easy to make that back.
1
This Tweet is from a suspended account. Learn more
This Tweet is from a suspended account. Learn more
Replying to
No disagreement that most people can't make an informed decision here. Would it be fair to say that you think that a primary purpose of the legal/regulatory framework that we have is protecting people from themselves?
1